This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Third Survey of Prescription Pattern of Psychotropic Drugs in China

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2012 by Si Tianmei, Peking University.
Recruitment status was:  Recruiting
Xian-Janssen Pharmaceutical Ltd.
Information provided by (Responsible Party):
Si Tianmei, Peking University Identifier:
First received: August 16, 2012
Last updated: August 17, 2012
Last verified: July 2012
The investigators aimed to examine the psychotropic prescription pattern in China.


Study Type: Observational
Study Design: Observational Model: Ecologic or Community
Time Perspective: Prospective
Official Title: The Third Survey on China Psychotropic Prescription for Schizophrenia, Depression and Bipolar Disorder

Resource links provided by NLM:

Further study details as provided by Si Tianmei, Peking University:

Estimated Enrollment: 7000
Study Start Date: July 2012
Estimated Study Completion Date: July 2013
Estimated Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Beijing region
include six hospitals
Guangdong Province
include 3 hospitals
Jiangsu province
include 3 hospitals
Hebei province
include 6 hospitals
Hubei Province
include 7 hospitals
Shanxi province
include 3 hospitals
Jiangxi province
include 3 hospitals
Jilin province
include 6 hospitals
Sichuan province
include 3 hospitals
Shaanxi province
include 3 hospitals


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
schizophrenia, depression and bipolar disorder patients

Inclusion Criteria: aged 18-65, inpatient or outpatient, Patient must be willing and able to give written informed consent,the patient suffers from schizophrenia or depression or bipolar disorder -

Exclusion Criteria:aged<18or aged>65

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01668810

Contact: Yun-Ai Su, Phd. 8610-82801960

China, Beijing
Institute of mental health, Peking University Recruiting
Beijing, Beijing, China, 100191
Contact: Tianmei Si, PhD.    8610-82801960   
Principal Investigator: Tianmei Si, PhD.         
Sponsors and Collaborators
Peking University
Xian-Janssen Pharmaceutical Ltd.
Study Chair: Xin Yu, MD. Peking University
  More Information

Responsible Party: Si Tianmei, Professor, Peking University Identifier: NCT01668810     History of Changes
Other Study ID Numbers: RISSCH4255
Study First Received: August 16, 2012
Last Updated: August 17, 2012

Keywords provided by Si Tianmei, Peking University:
bipolar disorder

Additional relevant MeSH terms:
Bipolar Disorder
Bipolar and Related Disorders
Mental Disorders
Psychotropic Drugs processed this record on August 18, 2017